Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 301–350 of 1,506 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07420517	Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer(DutaBCa-1)	recruiting	Phase 2	95	Paul TorenOTHER	1	Mar 30, 2026	clinicaltrials
NCT05226117	Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer	completed	Phase 2	44	IRCCS San RaffaeleOTHER	1	Mar 27, 2026	clinicaltrials